Clinical trialNCT04294043RecruitingPhase 1Interventional

IV Gallium Study for Patients With Cystic Fibrosis Who Have NTM (ABATE Study)

SponsorChris GossEnrollment40Nontuberculous Mycobacterium Infection

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to assess the safety and tolerability of two 5-day infusion cycles of IV gallium in adult patients with CF who are infected with NTM. Funding Source - FDA Office of Orphan Products Development (OOPD)

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Christopher H. Goss, MD, MSc
University of Washington, Seattle Children's Hospital
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

University of Alabama at Birmingham
Birmingham, Alabama, United States
Recruiting
National Jewish Health
Denver, Colorado, United States
Recruiting
Johns Hopkins University
Baltimore, Maryland, United States
Recruiting
the Minnesota Cystic Fibrosis Center
Minneapolis, Minnesota, United States
Recruiting
Nationwide Children'S Hospital
Columbus, Ohio, United States
Recruiting
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
Recruiting
Medical University of South Carolina
Charleston, South Carolina, United States
Recruiting
University of Texas Southwestern
Dallas, Texas, United States
Recruiting
University of Vermont Medical Center
Burlington, Vermont, United States
Recruiting
University of Washington Medical Center
Seattle, Washington, United States
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Gallium

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 17 Jun 2021
Primary completion: 31 Mar 2027
Completion: 31 Mar 2027
Last update posted: 1 Oct 2025
Registered enrollment: 40
Registry id: NCT04294043

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.